Nuveen’s Transmedics TMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.27M | Buy |
79,310
+891
| +1% | +$75.4K | ﹤0.01% | 2065 |
|
|
2026
Q1 | $7.8M | Buy |
78,419
+3,256
| +4% | +$425K | ﹤0.01% | 1689 |
|
|
2025
Q4 | $9.14M | Sell |
75,163
-1,203
| -2% | -$151K | ﹤0.01% | 1604 |
|
|
2025
Q3 | $8.57M | Sell |
76,366
-950
| -1% | -$111K | ﹤0.01% | 1637 |
|
|
2025
Q2 | $10.4M | Sell |
77,316
-10,780
| -12% | -$1.18M | ﹤0.01% | 1485 |
|
|
2025
Q1 | $5.93M | Buy |
88,096
+963
| +1% | +$66.2K | ﹤0.01% | 1834 |
|
|
2024
Q4 | $5.43M | Sell |
87,133
-98,195
| -53% | -$9.14M | ﹤0.01% | 1946 |
|
|
2024
Q3 | $29.1M | Buy |
185,328
+21,001
| +13% | +$3.24M | 0.01% | 945 |
|
|
2024
Q2 | $24.8M | Buy |
164,327
+79,967
| +95% | +$9.6M | 0.01% | 993 |
|
|
2024
Q1 | $6.24M | Sell |
84,360
-2,189
| -3% | -$180K | ﹤0.01% | 1861 |
|
|
2023
Q4 | $6.83M | Buy |
86,549
+1,946
| +2% | +$117K | ﹤0.01% | 1799 |
|
|
2023
Q3 | $4.63M | Sell |
84,603
-514
| -0.6% | -$37K | ﹤0.01% | 1903 |
|
|
2023
Q2 | $7.15M | Buy |
85,117
+2,195
| +3% | +$168K | ﹤0.01% | 1711 |
|
|
2023
Q1 | $6.28M | Sell |
82,922
-12,270
| -13% | -$849K | ﹤0.01% | 1758 |
|
|
2022
Q4 | $5.88M | Sell |
95,192
-18,687
| -16% | -$993K | ﹤0.01% | 1821 |
|
|
2022
Q3 | $4.75M | Sell |
113,879
-8,971
| -7% | -$390K | ﹤0.01% | 1935 |
|
|
2022
Q2 | $3.86M | Buy |
122,850
+16,524
| +16% | +$441K | ﹤0.01% | 2117 |
|
|
2022
Q1 | $2.46M | Sell |
106,326
-35,185
| -25% | -$630K | ﹤0.01% | 2405 |
|
|
2021
Q4 | $2.71M | Sell |
141,511
-912
| -0.6% | -$22.9K | ﹤0.01% | 2414 |
|
|
2021
Q3 | $4.71M | Buy |
142,423
+20,465
| +17% | +$625K | ﹤0.01% | 2250 |
|
|
2021
Q2 | $4.05M | Sell |
121,958
-55,751
| -31% | -$1.55M | ﹤0.01% | 2351 |
|
|
2021
Q1 | $7.37M | Buy |
177,709
+83,489
| +89% | +$2.57M | ﹤0.01% | 1960 |
|
|
2020
Q4 | $1.88M | Sell |
94,220
-663
| -0.7% | -$9.8K | ﹤0.01% | 2546 |
|
|
2020
Q3 | $1.31M | Buy |
94,883
+21,069
| +29% | +$361K | ﹤0.01% | 2570 |
|
|
2020
Q2 | $1.32M | Buy |
73,814
+31,583
| +75% | +$494K | ﹤0.01% | 2504 |
|
|
2020
Q1 | $510K | Buy |
42,231
+44
| +0.1% | +$737 | ﹤0.01% | 2765 |
|
|
2019
Q4 | $802K | Buy |
42,187
+32,416
| +332% | +$595K | ﹤0.01% | 2764 |
|
|
2019
Q3 | $232K | Hold |
9,771
| – | – | ﹤0.01% | 3094 |
|
|
2019
Q2 | $283K | Buy |
+9,771
| New | +$267K | ﹤0.01% | 3123 |
|
Other funds holding TMDX
Nuveen's TMDX Position: Q2 2026 in Review
Nuveen increased its Transmedics (TMDX) stake by 1.1% in Q2 2026, buying an estimated $75.4K and bringing the position to 79,310 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2065.
Nuveen first reported a position in TMDX in Q2 2019 and has held it in 29 quarters since. The position peaked at $29.1M in Q3 2024. 377 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.
- Nuveen held 79,310 shares of Transmedics worth $5.27M as of Q2 2026.
- Nuveen bought 891 Transmedics shares in Q2 2026, an estimated $75.4K.
- Transmedics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2065 holding.
- Nuveen first reported a position in Transmedics in Q2 2019 and has held it in 29 quarters since.
- Nuveen's Transmedics position peaked at $29.1M in Q3 2024.
- 377 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.